NO874764D0 - Fremgangsmaate for fremstilling av 2-aminopurinderivater. - Google Patents

Fremgangsmaate for fremstilling av 2-aminopurinderivater.

Info

Publication number: NO874764D0
Authority: NO; Norway
Prior art keywords: aminopurin; derivatives; procedure; preparation; aminopurin derivatives
Prior art date: 1984-09-20

Application number

NO1987874764A

Other languages

English (en)

Other versions

NO167572B (no

NO874764L (no

NO167572C (no

Inventor

Michael Raymond Harnden

Richard Lewis Jarvest

Original Assignee

Beecham Group Plc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1984-09-20

Filing date

1987-11-16

Publication date

1987-11-16

1984-09-20 Priority claimed from GB848423833A external-priority patent/GB8423833D0/en

1985-04-23 Priority claimed from GB858510331A external-priority patent/GB8510331D0/en

1985-08-16 Priority claimed from GB858520618A external-priority patent/GB8520618D0/en

1987-11-16 Application filed by Beecham Group Plc filed Critical Beecham Group Plc

1987-11-16 Publication of NO874764D0 publication Critical patent/NO874764D0/no

1987-11-16 Publication of NO874764L publication Critical patent/NO874764L/no

1991-08-12 Publication of NO167572B publication Critical patent/NO167572B/no

1991-11-20 Publication of NO167572C publication Critical patent/NO167572C/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/007—Esters of unsaturated alcohols having the esterified hydroxy group bound to an acyclic carbon atom
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
- C07F9/65616—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system having three or more than three double bonds between ring members or between ring members and non-ring members, e.g. purine or analogs

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Virology (AREA)
General Health & Medical Sciences (AREA)
General Chemical & Material Sciences (AREA)
Public Health (AREA)
Communicable Diseases (AREA)
Chemical Kinetics & Catalysis (AREA)
Molecular Biology (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Oncology (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Biotechnology (AREA)
Engineering & Computer Science (AREA)
Biochemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

NO87874764A 1984-09-20 1987-11-16 Analogifremgangsmaate for fremstilling av et terapeutisk aktivt purinderivat. NO167572C (no)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
GB848423833A GB8423833D0 (en)	1984-09-20	1984-09-20	Compounds
GB858510331A GB8510331D0 (en)	1985-04-23	1985-04-23	Compounds
GB858520618A GB8520618D0 (en)	1985-08-16	1985-08-16	Compounds
PCT/GB1986/000153 WO1987005604A1 (en)	1984-09-20	1986-03-17	2-aminopurine derivatives and process for their preparation

Publications (4)

Publication Number	Publication Date
NO874764D0 true NO874764D0 (no)	1987-11-16
NO874764L NO874764L (no)	1987-11-16
NO167572B NO167572B (no)	1991-08-12
NO167572C NO167572C (no)	1991-11-20

Family

ID=27262464

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO87874764A NO167572C (no)	1984-09-20	1987-11-16	Analogifremgangsmaate for fremstilling av et terapeutisk aktivt purinderivat.

Country Status (24)

Country	Link
EP (1)	EP0182024B1 (no)
JP (2)	JPS6185388A (no)
KR (1)	KR930006349B1 (no)
AT (1)	AT389118B (no)
AU (1)	AU589371B2 (no)
BG (1)	BG61493B2 (no)
CA (1)	CA1262899A (no)
CY (1)	CY1747A (no)
CZ (1)	CZ283721B6 (no)
DE (1)	DE3582399D1 (no)
DK (1)	DK167019B1 (no)
ES (1)	ES8703876A1 (no)
FI (1)	FI87564C (no)
GR (1)	GR852272B (no)
HK (1)	HK128693A (no)
HU (1)	HU198934B (no)
IE (1)	IE58141B1 (no)
MX (1)	MX165116B (no)
MY (1)	MY102473A (no)
NL (1)	NL960006I1 (no)
NO (1)	NO167572C (no)
NZ (1)	NZ213528A (no)
PT (1)	PT81160B (no)
WO (1)	WO1987005604A1 (no)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE8406538D0 (sv) *	1984-12-21	1984-12-21	Astra Laekemedel Ab	Novel derivatives of purine
GB8628826D0 (en) *	1986-12-02	1987-01-07	Beecham Group Plc	Pharmaceutical products
US5175288A (en) *	1987-08-01	1992-12-29	Beecham Group P.L.C.	Process for preparing purine derivatives and intermediates thereof
DE3855774T2 (de) *	1987-08-01	1997-06-12	Beecham Group Plc	Purinverbindungen und ihre Herstellung
GB8817270D0 (en) *	1988-07-20	1988-08-24	Beecham Group Plc	Novel process
GB8817607D0 (en) *	1988-07-23	1988-09-01	Beecham Group Plc	Novel process
GB8822236D0 (en) *	1988-09-21	1988-10-26	Beecham Group Plc	Chemical process
CA2009110A1 (en) *	1989-02-02	1990-08-02	Richard L. Tolman	Cyclic monophosphates of purine and pyrimidine acyclonucleosides
CA2009109A1 (en) *	1989-02-02	1990-08-02	John Hannah	Antiviral acyclonucleosides and acyclonucleotides
GB8904855D0 (en) *	1989-03-03	1989-04-12	Beecham Group Plc	Pharmaceutical treatment
GB8922076D0 (en) *	1989-09-28	1989-11-15	Beecham Group Plc	Novel process
GB9004647D0 (en) *	1990-03-01	1990-04-25	Beecham Group Plc	Pharmaceuticals
GB9102127D0 (en) *	1991-01-31	1991-03-13	Smithkline Beecham Plc	Pharmaceuticals
GB9201961D0 (en)	1992-01-30	1992-03-18	Smithkline Beecham Plc	Pharmaceuticals
GB9326177D0 (en) *	1993-12-22	1994-02-23	Smithkline Beecham Plc	Pharmaceuticals
IL111138A (en) *	1993-10-05	1997-04-15	Smithkline Beecham Plc	Pharmaceutical compositions comprising penciclovir and/or its bioprecursor and/or its derivatives for the treatment and prophylaxis of post-herpetic neuralgia
US6124304A (en) *	1993-10-05	2000-09-26	Smithkline Beecham Plc	Penciclovir for the treatment of zoster associated pain
US6683084B1 (en)	1993-11-12	2004-01-27	Novartis International Pharmaceutical Ltd.	Use of 2-amino purine derivatives for the treatment and prophylaxis of human herpes virus 6 infections
GB9323403D0 (en) *	1993-11-12	1994-01-05	Smithkline Beecham Plc	Pharmaceuticals
GB9323404D0 (en) *	1993-11-12	1994-01-05	Smithkline Beecham Plc	Pharmaceuticals
GB9402161D0 (en) *	1994-02-04	1994-03-30	Wellcome Found	Chloropyrimidine intermediates
GB9407698D0 (en) *	1994-04-19	1994-06-15	Smithkline Beecham Plc	Pharmaceuticals
DE4420751A1 (de) *	1994-06-15	1995-12-21	Basf Ag	Verfahren zur Herstellung von enantiomerenreinen Lactamen
EP0784624A1 (en) *	1994-10-05	1997-07-23	Chiroscience Limited	Purine and guanine compounds as inhibitors of pnp
RU2181049C2 (ru) *	1994-12-12	2002-04-10	Новартис Интернэшнл Фармасьютикал Лтд.	Использование аминопуриновых противовирусных соединений для лечения и профилактики латентных инфекций, вызванных вирусом герпеса
GB9504497D0 (en) *	1995-03-07	1995-04-26	Smithkline Beecham Plc	Pharmaceuticals
GB9600847D0 (en) *	1996-01-16	1996-03-20	Smithkline Beecham Plc	Pharmaceuticals
AU1601397A (en) *	1996-02-07	1997-08-28	Smithkline Beecham Plc	Famciclovir monohydrate
US7279483B2 (en)	1996-02-07	2007-10-09	Novartis Ag	Famciclovir monohydrate
GB9615253D0 (en) *	1996-07-20	1996-09-04	Smithkline Beecham Plc	Pharmaceuticals
PT102030B (pt) *	1996-07-20	1999-04-30	Smithkline Beecham Plc	Processo para a apreparacao dos compostos penciclovir ou famciclovir que sao utesi como agentes antivirais
GB9615276D0 (en) *	1996-07-20	1996-09-04	Smithkline Beecham Plc	Pharmaceuticals
CA2251481A1 (en)	1997-11-12	1999-05-12	Junichi Yasuoka	Purine derivatives having cyclopropane ring
GB9807116D0 (en)	1998-04-02	1998-06-03	Smithkline Beecham Plc	Novel process
SI20022A (sl) *	1998-07-29	2000-02-29	Kemijski inštitut	Alkilno substituirani purinovi derivati in njihova priprava
CA2477088A1 (en)	2002-02-22	2003-10-02	New River Pharmaceuticals Inc.	Active agent delivery systems and methods for protecting and administering active agents
US20040097528A1 (en)	2002-08-26	2004-05-20	Ben-Zion Dolitzky	Crystalline solid famciclovir forms I, II, III and preparation thereof
EA201100293A1 (ru)	2003-01-14	2011-08-30	Джилид Сайэнс, Инк.	Способ (варианты) и фармацевтическая композиция (варианты) для лечения или профилактики симптомов вич-инфекции
AU2006230269A1 (en)	2005-03-30	2006-10-05	Novartis Ag	Penciclovir or famciclovir for the treatment of recurrent genital herpes with a one-day application
GB2426247A (en)	2005-05-20	2006-11-22	Arrow Int Ltd	Methods of preparing purine derivatives such as famciclovir
TWI471145B (zh)	2005-06-13	2015-02-01	Bristol Myers Squibb & Gilead Sciences Llc	單一式藥學劑量型
TWI375560B (en)	2005-06-13	2012-11-01	Gilead Sciences Inc	Composition comprising dry granulated emtricitabine and tenofovir df and method for making the same
WO2017029298A1 (en)	2015-08-17	2017-02-23	Sanovel Ilac Sanayi Ve Ticaret A.S.	A topical antiviral composition
US10364263B2 (en) *	2015-12-08	2019-07-30	Retrophin, Inc.	Cyclic phosphates and cyclic phosphoramidates for the treatment of neurologic disorders
WO2021209563A1 (en)	2020-04-16	2021-10-21	Som Innovation Biotech, S.A.	Compounds for use in the treatment of viral infections by respiratory syndrome-related coronavirus

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PT77494B (en) *	1982-10-14	1986-08-14	Wellcome Found	Antiviral compounds
EP0141927B1 (en) *	1983-08-18	1991-10-30	Beecham Group Plc	Antiviral guanine derivatives
AU577303B2 (en) *	1983-08-18	1988-09-22	Novartis International Pharmaceutical Ltd	9-substituted-2-amino purines
EP0152316B1 (en) *	1984-01-26	1989-07-26	Merck & Co. Inc.	Substituted butyl guanines and their utilization in antiviral compositions

1985
- 1985-09-09 DE DE8585111354T patent/DE3582399D1/de not_active Expired - Lifetime
- 1985-09-09 EP EP85111354A patent/EP0182024B1/en not_active Expired - Lifetime
- 1985-09-18 AU AU47560/85A patent/AU589371B2/en not_active Expired
- 1985-09-18 IE IE230785A patent/IE58141B1/en not_active IP Right Cessation
- 1985-09-18 DK DK424685A patent/DK167019B1/da not_active IP Right Cessation
- 1985-09-18 GR GR852272A patent/GR852272B/el unknown
- 1985-09-18 PT PT81160A patent/PT81160B/pt unknown
- 1985-09-18 CA CA000491028A patent/CA1262899A/en not_active Expired
- 1985-09-18 NZ NZ213528A patent/NZ213528A/xx unknown
- 1985-09-19 ES ES547128A patent/ES8703876A1/es not_active Expired
- 1985-09-19 JP JP60207693A patent/JPS6185388A/ja active Granted
- 1985-10-01 MX MX9010A patent/MX165116B/es unknown
1986
- 1986-03-17 WO PCT/GB1986/000153 patent/WO1987005604A1/en not_active Ceased
- 1986-03-17 HU HU863048A patent/HU198934B/hu unknown
- 1986-03-17 KR KR1019870701056A patent/KR930006349B1/ko not_active Expired - Lifetime
- 1986-03-17 AT AT0904286A patent/AT389118B/de not_active IP Right Cessation
1987
- 1987-09-29 MY MYPI87002221A patent/MY102473A/en unknown
- 1987-11-16 FI FI875059A patent/FI87564C/fi not_active IP Right Cessation
- 1987-11-16 NO NO87874764A patent/NO167572C/no unknown
1991
- 1991-12-19 CZ CS913915A patent/CZ283721B6/cs not_active IP Right Cessation
1993
- 1993-05-07 JP JP5130044A patent/JPH0826021B2/ja not_active Expired - Lifetime
- 1993-11-10 BG BG098209A patent/BG61493B2/bg unknown
- 1993-11-18 HK HK1286/93A patent/HK128693A/en not_active IP Right Cessation
1994
- 1994-06-03 CY CY174794A patent/CY1747A/xx unknown
1996
- 1996-04-09 NL NL960006C patent/NL960006I1/nl unknown

Also Published As

Publication number	Publication date
MX165116B (es)	1992-10-27
HU198934B (en)	1989-12-28
WO1987005604A1 (en)	1987-09-24
FI87564C (fi)	1993-01-25
EP0182024B1 (en)	1991-04-03
MY102473A (en)	1992-06-30
HK128693A (en)	1993-11-26
IE852307L (en)	1986-03-20
ATA904286A (de)	1989-03-15
GR852272B (no)	1986-01-21
CY1747A (en)	1994-06-03
PT81160B (pt)	1988-01-22
HUT47576A (en)	1989-03-28
FI875059A0 (fi)	1987-11-16
AU589371B2 (en)	1989-10-12
CZ283721B6 (cs)	1998-06-17
JPH0826021B2 (ja)	1996-03-13
JPH0586792B2 (no)	1993-12-14
AU4756085A (en)	1986-03-27
NO167572B (no)	1991-08-12
FI875059L (fi)	1987-11-16
CA1262899A (en)	1989-11-14
NL960006I2 (nl)	1996-09-02
DE3582399D1 (de)	1991-05-08
FI87564B (fi)	1992-10-15
ES547128A0 (es)	1987-03-01
NO874764L (no)	1987-11-16
JPS6185388A (ja)	1986-04-30
NL960006I1 (nl)	1996-09-02
NZ213528A (en)	1989-03-29
IE58141B1 (en)	1993-07-14
DK167019B1 (da)	1993-08-16
PT81160A (en)	1985-10-01
AT389118B (de)	1989-10-25
BG61493B2 (bg)	1997-09-30
CS391591A3 (en)	1992-05-13
NO167572C (no)	1991-11-20
EP0182024A3 (en)	1989-03-08
EP0182024A2 (en)	1986-05-28
KR930006349B1 (ko)	1993-07-14
DK424685D0 (da)	1985-09-18
ES8703876A1 (es)	1987-03-01
JPH0625241A (ja)	1994-02-01
DK424685A (da)	1986-03-21

Publication	Publication Date	Title
NO874764D0 (no)	1987-11-16	Fremgangsmaate for fremstilling av 2-aminopurinderivater.
NO870579L (no)	1987-08-17	Fremgangsmaate for fremstilling av indolizin-derivater.
NO852124L (no)	1985-12-02	Fremgangsmaate ved fremstilling av kinolonderivater.
NO821087L (no)	1982-10-07	Fremgangsmaate for fremstilling av cyklobutan-derivater.
NO865013D0 (no)	1986-12-11	Fremgangsmaate for fremstilling av antibaktercelle kinolon-derivater.
NO855067L (no)	1986-06-18	Fremgangsmaate for fremstilling av n-formyl-alfa-aspartyl-fenylalanin.
NO863251L (no)	1987-02-16	Fremgangsmaate for fremstilling av sphingosinderivater.
NO155693C (no)	1987-05-13	Fremgangsmaate for fremstilling av eburnamoninderivater.
NO164030C (no)	1990-08-22	Fremgangsmaate for fremstilling av imidazo-rifamycin-derivater.
NO165676C (no)	1991-03-20	Fremgangsmaate ved fremstilling av pyrrolidonderivater.
NO852810L (no)	1986-01-14	Fremgangsmaate ved fremstilling av fluorallylaminderivater.
NO860429L (no)	1986-08-11	Fremgangsmaate for fremstilling av imidazolyl-indol-derivater.
NO164772C (no)	1990-11-14	Fremgangsmaate for fremstilling av cefalosporinderivater.
NO165637C (no)	1991-03-13	Fremgangsmaate for fremstilling av etoksylert lignitt.
NO169441C (no)	1992-06-24	Fremgangsmaate til fremstilling av 7-oksomitosanderivater
NO874199D0 (no)	1987-10-07	Fremgangsmaate for fremstilling av imidazo-pyridinonderivater.
NO852796L (no)	1986-01-13	Fremgangsmaate for fremstilling av nitroapovincamin-syrederivater.
NO852418L (no)	1985-12-16	Fremgangsmaate for fremstilling av aminderivater.
NO161353C (no)	1989-08-09	Fremgangsmaate for fremstilling av pastiller.
NO863769D0 (no)	1986-09-22	Fremgangsmaate for fremstilling av 4-hydroksy-2-oksopyrrolin-1-yl-acetamid.
NO166709C (no)	1991-08-28	Fremgangsmaate for fremstilling av akrylamider.
NO851319L (no)	1985-10-03	Fremgangsmaate for fremstilling av eburnanderivater.
NO871721D0 (no)	1987-04-24	Fremgangsmaate for fremstilling av ergolenderivater.
NO864087D0 (no)	1986-10-14	Fremgangsmaate for fremstilling av aroylthiazoloner.
NO862493L (no)	1986-12-22	Fremgangsmaate for fremstilling av 2-halonicergolinderivater.